Coloplast A/S/€COLOB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Coloplast A/S
Coloplast A/S is a Danish multinational company that specializes in the development and manufacture of medical devices and services. The company's core business operates within the healthcare sector, offering products and services that focus on ostomy care, urology, continence care, and wound and skin care. Founded in 1957 and headquartered in Humlebæk, Denmark, Coloplast has established a strong presence in numerous countries, serving healthcare professionals and patients around the globe. Its strategic positioning is supported by a commitment to innovation and close collaboration with healthcare professionals to ensure the efficacy and safety of its offerings. Coloplast's competitive strengths derive from its comprehensive product portfolio and strong expertise in chronic care solutions.
Ticker
€COLOB
Sector
Primary listing
XGAT
Employees
16,814
Headquarters
Humlebæk, Denmark
Website
Coloplast A/S Metrics
BasicAdvanced
€19B
34.36
€2.42
0.55
€2.95
3.55%
Price and volume
Market cap
€19B
Beta
0.55
52-week high
€128.52
52-week low
€77.52
Average daily volume
2.5K
Dividend rate
€2.95
Financial strength
Current ratio
1
Quick ratio
0.612
Long term debt to equity
105.034
Total debt to equity
147.222
Dividend payout ratio (TTM)
121.67%
Interest coverage (TTM)
9.54%
Profitability
EBITDA (TTM)
1,141.376
Gross margin (TTM)
67.55%
Net profit margin (TTM)
14.62%
Operating margin (TTM)
27.19%
Effective tax rate (TTM)
34.33%
Revenue per employee (TTM)
€222,400
Management effectiveness
Return on assets (TTM)
9.82%
Return on equity (TTM)
24.72%
Valuation
Price to earnings (TTM)
34.363
Price to revenue (TTM)
5.024
Price to book
8.44
Price to tangible book (TTM)
-10.31
Price to free cash flow (TTM)
28.295
Free cash flow yield (TTM)
3.53%
Free cash flow per share (TTM)
2.941
Dividend yield (TTM)
3.55%
Growth
Revenue change (TTM)
5.95%
Earnings per share change (TTM)
-18.20%
3-year revenue growth (CAGR)
8.83%
10-year revenue growth (CAGR)
7.52%
3-year earnings per share growth (CAGR)
-6.96%
10-year earnings per share growth (CAGR)
1.97%
3-year dividend per share growth (CAGR)
5.01%
10-year dividend per share growth (CAGR)
11.36%
Bulls say / Bears say
Coloplast reported Q1 EBIT of DKK 1.54 billion, beating analysts’ forecast of DKK 1.48 billion, showing operational strength (Reuters)
The company launched a DKK 500 million share buyback programme, signaling management’s confidence in cash flow generation and commitment to returning capital to shareholders (Reuters)
Coloplast shares rose about 5% after the Q1 earnings release, highlighting positive investor sentiment about its growth outlook (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Coloplast A/S stock?
Coloplast A/S (COLOB) has a market cap of €19B as of September 16, 2025.
What is the P/E ratio for Coloplast A/S stock?
The price to earnings (P/E) ratio for Coloplast A/S (COLOB) stock is 34.36 as of September 16, 2025.
Does Coloplast A/S stock pay dividends?
Yes, the Coloplast A/S (COLOB) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is €2.94995 and the yield is 3.55%. Coloplast A/S has a payout ratio of 121.67% on a trailing twelve-month basis.
When is the next Coloplast A/S dividend payment date?
The next Coloplast A/S (COLOB) dividend payment date is unconfirmed.
What is the beta indicator for Coloplast A/S?
Coloplast A/S (COLOB) has a beta rating of 0.55. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.